MLTX20260116P17.5
MLTX Jan 16 2026 17.50 Put (MLTX260116P00017500)
option OPRA

moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.